OXT and Alzheimer disease: The levels of neuropeptides including oxytocin [29], insulin [30], VIP [31] and PACAP [32], all of which contribute to the control of synaptic plasticity in the hippocampus, have displayed adjustments in AD, resulting in aberrant control of LTP and LTD and subsequent interference of memory formation.